Sustained efficacy from 3 to 6 months following bronchoscopic thermal vapor ablation (BTVA) in the treatment of heterogeneous emphysema
F. Herth, G. Snell, P. Hopkins, K. Baker, C. Witt, M. H. Gotfried, A. Valipour, M. Wagner, F. Stanzel, J. Egan, S. Kesten, A. Ernst (Heidelberg, Berlin, Nuremberg, Hemer, Germany; Melbourne, Chermside, Australia; Iowa City, Phoenix, Tustin, Boston, United States Of America; Vienna, Austria; Dublin, Ireland)
Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope?
Session: Endoscopic lung volume reduction: hype or hope?
Session type: Oral Presentation
Number: 370
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Herth, G. Snell, P. Hopkins, K. Baker, C. Witt, M. H. Gotfried, A. Valipour, M. Wagner, F. Stanzel, J. Egan, S. Kesten, A. Ernst (Heidelberg, Berlin, Nuremberg, Hemer, Germany; Melbourne, Chermside, Australia; Iowa City, Phoenix, Tustin, Boston, United States Of America; Vienna, Austria; Dublin, Ireland). Sustained efficacy from 3 to 6 months following bronchoscopic thermal vapor ablation (BTVA) in the treatment of heterogeneous emphysema. Eur Respir J 2011; 38: Suppl. 55, 370
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: